Advances in immunotherapy for recurrent and metastatic cervical cancer
10.3760/cma.j.cn371439-20220520-00100
- VernacularTitle:复发转移性宫颈癌免疫治疗相关进展
- Author:
Lu ZHANG
1
;
Juying ZHOU
;
Chenying MA
;
Zhou LIN
Author Information
1. 苏州大学附属第一医院放疗科，苏州 215006
- Keywords:
Uterine cervical neoplasms;
Recurrence;
Neoplasm metastasis;
Immunotherapy;
Therapeutics
- From:
Journal of International Oncology
2022;49(9):517-520
- CountryChina
- Language:Chinese
-
Abstract:
Immunotherapy mainly includes simple immunotherapy (immune checkpoint inhibitor, therapeutic human papillomavirus vaccine, adoptive T cell therapy, double immunotherapy, etc.) , immunotherapy combined with other treatments (such as chemotherapy, antiangiogenic therapy, radiotherapy, etc.) . The continuous development of immunotherapy and the improvement of treatment scheme have improved the survival and prognosis of patients, and provided new ideas for the diagnosis and treatment of recurrent and metastatic cervical cancer.
